HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Miriam Wittmann Selected Research
Miriam Wittmann Research Topics
Disease
21
Inflammation (Inflammations)
01/2021 - 12/2003
18
Psoriasis (Pustulosis Palmaris et Plantaris)
10/2022 - 12/2003
14
Skin Diseases (Skin Disease)
11/2021 - 06/2005
11
Eczema
02/2022 - 06/2005
7
Psoriatic Arthritis
01/2022 - 06/2013
7
Necrosis
01/2020 - 12/2003
5
Rheumatoid Arthritis
10/2022 - 01/2018
5
Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2022 - 06/2015
4
Autoimmune Diseases (Autoimmune Disease)
10/2022 - 07/2006
4
Cutaneous Lupus Erythematosus
06/2013 - 10/2008
3
Spondylarthropathies
10/2022 - 01/2019
3
Arthritis (Polyarthritis)
10/2022 - 01/2021
2
Enthesopathy
10/2022 - 01/2019
2
Atopic Dermatitis (Atopic Eczema)
01/2021 - 02/2013
2
Neoplasms (Cancer)
12/2015 - 03/2010
1
Drug-Related Side Effects and Adverse Reactions
10/2022
1
Anterior Uveitis
11/2021
1
Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
11/2021
1
Food Hypersensitivity (Food Allergy)
11/2021
1
Asthma (Bronchial Asthma)
11/2021
1
Joint Diseases (Joint Disease)
01/2021
1
Osteoarthritis
11/2019
1
Rosacea (Acne Rosacea)
01/2019
1
Connective Tissue Diseases (Connective Tissue Disease)
10/2018
1
Fever (Fevers)
01/2018
1
Persistent Infection
08/2015
1
Disease Progression
04/2015
1
Pruritus (Itching)
08/2014
1
Chronic Obstructive Pulmonary Disease (COPD)
06/2013
1
Mitochondrial Diseases (Mitochondrial Disease)
08/2012
1
Type 2 Diabetes Mellitus (MODY)
08/2012
1
Superinfection
06/2012
1
Melanoma (Melanoma, Malignant)
12/2011
1
Cryopyrin-Associated Periodic Syndromes
03/2010
1
Gout
03/2010
Drug/Important Bio-Agent (IBA)
16
Cytokines
IBA
10/2022 - 12/2003
7
Proteins (Proteins, Gene)
FDA Link
01/2020 - 10/2006
6
Interleukin-12 (IL 12)
IBA
06/2019 - 10/2004
5
Interleukin-13
IBA
10/2022 - 05/2006
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2018 - 12/2003
5
Interleukin-18 (Interleukin 18)
IBA
01/2012 - 12/2003
4
Interferons
IBA
12/2020 - 06/2005
4
Interleukins
IBA
01/2020 - 06/2005
4
Interleukin-27 (Interleukin 27)
IBA
06/2019 - 07/2009
3
dupilumab
IBA
10/2022 - 01/2021
3
Biomarkers (Surrogate Marker)
IBA
01/2022 - 04/2015
3
Interleukin-17 (Interleukin 17)
IBA
11/2021 - 12/2010
3
Interleukin-23 (Interleukin 23)
IBA
01/2021 - 06/2015
3
Inflammasomes
IBA
08/2012 - 03/2010
2
Biological Products
IBA
10/2022 - 01/2016
2
Interleukin-1 (Interleukin 1)
IBA
01/2021 - 01/2018
2
Interferon Type I
IBA
12/2020 - 01/2020
2
apremilast
IBA
01/2020 - 06/2013
2
Ustekinumab (CNTO 1275)
FDA Link
01/2019 - 06/2015
2
Lipopolysaccharides
IBA
01/2018 - 12/2003
2
Type I Tumor Necrosis Factor Receptors
IBA
01/2018 - 08/2012
2
Histamine (Histamine Dihydrochloride)
FDA Link
12/2008 - 05/2005
2
Interferon-gamma (Interferon, gamma)
IBA
12/2008 - 12/2003
1
Interleukin-13 Receptors (Interleukin 13 Receptor)
IBA
10/2022
1
Alitretinoin
FDA Link
02/2022
1
Peptide Hydrolases (Proteases)
FDA Link
01/2021
1
Interleukin-4 (Interleukin 4)
IBA
01/2021
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
12/2020
1
Anti-Citrullinated Protein Antibodies
IBA
10/2020
1
amsonic acid (DAS)
IBA
01/2020
1
Bone Marrow Stromal Antigen 2
IBA
01/2020
1
Interleukin-23 Subunit p19
IBA
06/2019
1
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
10/2018
1
Antinuclear Antibodies
IBA
10/2018
1
Janus Kinases
IBA
01/2018
1
tofacitinib
IBA
01/2018
1
Janus Kinase Inhibitors
IBA
01/2018
1
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2018
1
protease S
IBA
01/2017
1
cathepsin S
IBA
01/2017
1
Enzymes
IBA
01/2016
1
Leukocyte Elastase (Neutrophil Elastase)
IBA
01/2016
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
12/2015
1
Collagen
IBA
12/2015
1
Oncogene Proteins (Oncogene Protein)
IBA
08/2015
1
Imiquimod (Aldara)
FDA Link
Generic
08/2015
1
Rituximab (Mabthera)
FDA Link
06/2015
1
Pharmaceutical Preparations
IBA
04/2015
1
Type 4 Cyclic Nucleotide Phosphodiesterases
IBA
06/2013
1
Phosphodiesterase 4 Inhibitors
IBA
06/2013
1
Monoclonal Antibodies
IBA
06/2013
1
Tumor Necrosis Factor Inhibitors
IBA
06/2013
1
Roflumilast
IBA
06/2013
1
Methotrexate (Mexate)
FDA Link
Generic
06/2013
1
Interleukin-33
IBA
02/2013
1
Autoantibodies
IBA
08/2012
1
Cytokine Receptors (Cytokine Receptor)
IBA
08/2012
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
08/2012
1
Antigens
IBA
08/2012
1
Suppressor of Cytokine Signaling Proteins
IBA
03/2012
1
Chemokines
IBA
12/2010
Therapy/Procedure
8
Therapeutics
01/2022 - 07/2006
1
Surgical Tape
01/2019
1
Topical Administration
01/2019
1
Retreatment
01/2018